Glycine

Glycine is an amino acid that is a building block of proteins, is synthesized in the body from serine and makes up every third residue in collagen. The benefit of supplementation has been examined most for sleep; results rest on small and mostly company-linked studies.

Bottom lineGlycine is an amino acid the body makes; benefit of supplementation has been reported for sleep in small and mostly company-linked studies, and evidence in schizophrenia, metabolic syndrome and aging is very limited.

What does it do in the body?

  • Protein and collagen: It is a building block of proteins; it takes part in forming collagen's tight helical structure.
  • Antioxidant production: It is used in making glutathione, one of the cell's antioxidants.
  • Heme and creatine production: It takes part in producing the heme group in hemoglobin and creatine in energy metabolism.
Explore the details

At a glance

  • Glycine is an amino acid used in protein synthesis and in making structures such as glutathione, creatine, purines and the heme in hemoglobin, and it is the most abundant amino acid in collagen. [3]
  • That the body’s glycine synthesis may not be enough to meet collagen requirements is a hypothesis based on a calculation model; it is not a measured deficiency. [2]
  • The 3 g evening dose used in sleep studies is three times the daily limit of 1,000 mg set for food supplements in Türkiye. [4] [11]
  • A significant share of the authors of the sleep studies are linked to a Japanese amino acid and food company. [5]
  • This guide does not set a personal dose.

What is glycine and what does it do in the body?

Glycine is generally counted among the nonessential amino acids. [6] Apart from protein synthesis, it is also used in the synthesis of serine, glutathione, creatine, purines and the heme in hemoglobin. [3]

Collagen is a protein particularly rich in glycine: the tight packing of the triple helix requires every third residue to be glycine. [1] Collagen supplements are a separate subject; their evidence is covered in the collagen guide. Glycine being present in collagen does not mean that taking a glycine supplement would increase collagen production.

Does the body make enough glycine?

This question is the basis of the view that counts glycine as “semi-essential.” The 2009 study by Meléndez-Hevia and colleagues is a computational analysis comparing reported glycine production and consumption flows in an adult human (not a new experiment). According to the authors, more than 85% of glycine is synthesized from serine; the amount synthesized is about 3 g/day and that from food 1.5–3.0 g/day, and the total may fall short of the amount required by all uses, including collagen synthesis, in a 70 kg adult by about 10 g a day. From this the authors conclude that glycine is semi-essential and should be taken as a supplement. [2]

This conclusion is a hypothesis: it is not a measured deficiency or a health outcome corrected by supplementation, but the output of a flow calculation. The study did not measure a clinical outcome. For mean glycine intake from all sources in people, 3.21 g a day is cited based on US Food and Nutrition Board (FNB/IOM 2005) data. [3]

What are daily glycine intake and requirement?

Because glycine is an amino acid the body can synthesize from serine, it is generally not counted as essential. The review by Blachier and colleagues gives no requirement value (RDA or adequate intake) for glycine, only intake data: according to US Food and Nutrition Board (FNB/IOM 2005) data, mean glycine intake from all sources is 3.21 g a day. [3] Meléndez-Hevia and colleagues estimate intake from food in the range of 1.5–3.0 g/day. [2] The two estimates rest on different methods and may not represent the same population; a person’s actual intake varies with diet.

For whom does glycine supplementation work? Evidence summary

TopicSituation examinedLimit of the evidence
SleepVolunteers with sleep complaints; healthy, partially sleep-restricted volunteers; a single evening dose of 3 gSmall studies; some of the authors linked to the same company; the systematic review notes risk of bias. [4] [7]
Schizophrenia18 short-term trials, 358 people (Cochrane 2006)Add-on to antipsychotic; small, inconsistent results. [8]
Metabolic syndrome60 people, 3 months, 15 g/dayA single small RCT, biomarker. [9]
GlyNAC in older adults24 older adults, 16 weeksGlycine + NAC together; 12 versus 12. [10]
Detailed guideGlycine benefits: claim-by-claim evidence and funding

Does glycine improve sleep quality?

Among the authors of the three studies covered here are people linked to the same Japanese amino acid and food company. The 2006 study by Inagawa and colleagues is a randomized, double-blind, crossover trial comparing 3 g of glycine before bed with placebo in 19 volunteers who complained of sleep quality; the subjective state the next morning was assessed with two questionnaires, and glycine produced a significant improvement on the items “fatigue,” “vigor and energy” and “clear-headedness.” [4] [7] In the 2007 study by Yamadera and colleagues, in volunteers who persistently slept inadequately, 3 g of glycine before bed improved subjective sleep quality and sleep efficiency (sleep time/time in bed) and, on polysomnography, shortened the latency to sleep onset and to slow-wave sleep; sleep architecture did not change. [5] Bannai and colleagues reported, in healthy volunteers whose sleep was restricted by 25% for three nights, in a single-blind, randomized, crossover design, that 3 g of glycine significantly reduced the next-day fatigue score and showed a trend toward reduced sleepiness; the analysis rests on data from only 7 people. [6]

The limitations of these studies are as follows: among the authors are employees of the same company (according to the article citations, four of the five authors of Inagawa 2006 and three of the six authors of Yamadera 2007 are affiliated with the company’s research units; the authors of Bannai 2012 are from the company’s research laboratory, the study protocol was approved by the company’s ethics committee, and the article reports no conflict of interest); results rest on subjective questionnaires; the samples are small; only short-term use has been examined. As a second look, the systematic review published in GeroScience, covering 18 studies in healthy and 34 in patient populations, states that sleep improved in studies in which glycine was used for longer in healthy people, but that these studies had small samples and a high risk of bias. [7] The evidence is therefore read as “promising but limited.”

Does glycine work as an add-on treatment in schizophrenia?

The Cochrane review (search up to 2003) covered 18 short-term trials (358 participants; 6–51 people per trial, at most 12 weeks) examining glutamatergic substances as an add-on to antipsychotic medicines; the substances used were glycine, D-serine, D-cycloserine and the ampakine CX516. Glycine and D-serine, co-agonists of the NMDA receptor, produced a moderate-size reduction in negative symptoms (n = 132; SMD −0.66; 95% CI −1.0 to −0.3); however, there was inconsistency in the response-rate analysis for glycine, and no significant effect was seen on positive symptoms and cognitive function. The authors stated that the data were too few for definitive conclusions. [8] These data are old and small; treatment of schizophrenia is carried out by a physician with antipsychotic medicines, and glycine has been examined as a substance added on top of them, not in place of them.

Does glycine work in metabolic syndrome and aging?

In the study by Díaz-Flores and colleagues in Mexico, 60 volunteers with metabolic syndrome (30 glycine 15 g/day, 30 placebo) were followed for 3 months. In the glycine group, plasma TBARS (a marker of lipid peroxidation) fell 25% compared with placebo; superoxide dismutase activity fell 20%; systolic blood pressure fell significantly only in men given glycine (p = 0.043). [9] These are markers of oxidative stress, not clinical outcomes such as cardiovascular events; it is a single, small study.

In the GlyNAC study of Kumar and colleagues, 24 older adults took glycine + N-acetylcysteine (GlyNAC) or an isonitrogenous alanine placebo for 16 weeks (12 versus 12); 12 young adults also took GlyNAC for 2 weeks. In older adults, baseline indicators of glutathione deficiency, oxidative stress and mitochondrial dysfunction improved with GlyNAC and did not with placebo; the product was safe and well tolerated. The study was funded by the US National Institutes of Health (NIH/NIA) and a charitable donation, and no conflict of interest was reported. [10] The result belongs to the glycine + NAC combination and cannot be attributed to glycine alone. In Türkiye, N-acetyl-L-cysteine was not found suitable for use as an active substance in food supplements. [11]

Is glycine safe?

The review by Blachier and colleagues cites the no-observed-adverse-effect level (NOAEL) for glycine in humans as 129.0 mg/kg body weight/day, citing the short-term Inagawa 2006 sleep study; this is not an official upper limit, is derived only from the dose tried in that study, and was used in the review to scale to usual intake. One of the authors of the review is an employee of the same company. [3] In the GlyNAC study, 16 weeks of use was reported as safe and well tolerated. [10] There is a large difference between the 15 g/day used in the metabolic syndrome study and the 3 g in the sleep studies; safety data also differ with the purpose and the person for whom the dose is used.

Are magnesium glycinate and free glycine the same?

The substance used in the studies in this guide is the free amino acid glycine. Mineral–amino acid compounds such as magnesium glycinate are separate products and were not used in the sleep, schizophrenia or metabolic syndrome studies examined here; the results of these studies therefore cannot be transferred to those products. Magnesium forms are covered in a separate guide: magnesium forms.

Which questions should be asked when evaluating a supplement?

For what purpose will it be used: a sleep complaint, a psychiatric illness, a vague expectation of renewal? Is there a controlled trial for this purpose, in whom was it done and who wrote it? Is the dose used in studies (3 g, 15 g) above the supplement limit in Türkiye (1,000 mg/day)? [11] Does the product contain glycine alone or another active substance together with glycine (for example N-acetylcysteine)? [10] The answers to these questions vary from person to person; for this reason the results should not be read as personal recommendations.

What is glycine’s status in Türkiye?

Glycine appears in the Ministry of Agriculture and Forestry’s Restricted Substances List for food supplements. In the list dated 21/09/2026, chemical synthesis and bovine protein hydrolysis are given as sources and a maximum daily intake of 1,000 mg for ages 11 and over; no limit is entered for the 4–10 age group. [11] The 3 g in sleep studies and the 15 g in the metabolic syndrome study are above this limit. The Food Supplements Communiqué also makes mandatory on the labels of these products the statement “not a medicine” and the warning that a doctor should be consulted in pregnancy, breastfeeding, illness or medicine use. [12] Safety data specific to glycine supplements in pregnancy and breastfeeding are limited.

This guide does not recommend a personal dose; if there is a persistent sleep problem, psychiatric illness or regular medicine use, the decision is made with a physician.

What does the evidence say?

What it does and does not affect
What do the A–E grades mean?

The letter describes the strength of evidence for a specific claim, not the size of the benefit or a usage recommendation. E does not mean ineffectiveness has been proven.

AStrong
Established physiology (e.g. correcting a deficiency) or strong, consistent, direct human studies
BModerate
Supportive human evidence; small effect or some limitations
CLimited
A single randomised trial, mixed results or low-certainty human findings
DInsufficient
Small, uncontrolled or indirect evidence; not enough to judge
ENo benefit shown / not studied in humans
No benefit shown for the claim, or only animal or cell data exist

These grades are Half-Life Journal’s editorial evidence summary; they are not a formal GRADE rating or independent medical approval.

The letter shows evidence strength; it is not a score for positive effect or a usage recommendation.

Frequently asked questions

What is glycine good for?

Glycine is an amino acid involved in protein building, collagen, glutathione synthesis and nerve transmission. The benefit of supplementation has been examined most for sleep; results come from small and mostly company-linked studies, and evidence in other areas is very limited.

Does glycine help with sleep?

There are small studies in volunteers with sleep problems in which 3 g of glycine before bed improved subjective sleep quality and the perception of fatigue the next morning; some of the authors of these studies are linked to an amino acid company. A systematic review notes that long-term studies in healthy people are small and at high risk of bias.

Does glycine increase collagen production?

In the triple helix of collagen, every third residue is glycine. That the body's glycine synthesis may not be enough to meet collagen requirements is a hypothesis; that supplementation increases collagen production has not been shown in clinical trials.

Does glycine supplementation have side effects?

In the 16-week GlyNAC study (24 older adults), the product was reported to be safe and well tolerated. The no-observed-adverse-effect level (NOAEL) cited for humans in a review is 129 mg/kg/day; it is derived from a single short-term study and is not an official upper limit.

Is there a daily limit for glycine supplements in Türkiye?

The Ministry of Agriculture and Forestry's list for food supplements gives a daily maximum of 1,000 mg for glycine at ages 11 and over (list dated 21/09/2026). The 3 g used in sleep studies is above this.

Sources

  1. Guideline / review Shoulders ve Raines — Collagen structure and stability (Annu Rev Biochem) (2009)Back to text ↑
  2. Source A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis. (2009)Back to text ↑
  3. Guideline / review Blachier et al. — Tolerable amounts of amino acids for human supplementation: summary and lessons from published peer-reviewed studies (Amino Acids) (2021)Back to text ↑
  4. RCT Inagawa et al. — Subjective effects of glycine ingestion before bedtime on sleep quality (Sleep Biol Rhythms) (2006)Back to text ↑
  5. Human study Yamadera et al. — Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes (Sleep Biol Rhythms) (2007)Back to text ↑
  6. RCT The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. (2012)Back to text ↑
  7. Guideline / review Soh et al. — The effect of glycine administration on the characteristics of physiological systems in human adults: a systematic review (GeroScience) (2023)Back to text ↑
  8. Meta-analysis Glutamatergic drugs for schizophrenia. (2006)Back to text ↑
  9. RCT Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure. (2013)Back to text ↑
  10. RCT Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. (2023)Back to text ↑
  11. Institution T.C. Tarım ve Orman Bakanlığı — Takviye Edici Gıdalar Kısıtlı Maddeler Listesi (son güncelleme 21/09/2026) (2026)Back to text ↑
  12. Institution Türk Gıda Kodeksi Takviye Edici Gıdalar Tebliği (Tebliğ No: 2013/49), Resmî Gazete 16 Ağustos 2013, sayı 28737 (2013)Back to text ↑

Method: Institutional clinical guidance and relevant studies were compared. Each finding is presented with its population, outcome, sources and limitations. Independent medical review has not yet been completed.

Updated

This content is for information only and is not medical advice. It does not recommend doses, products or vendors. Talk to your clinician before making any health decision.